Atlas Trials

Lymphoma, Large B-Cell, Diffuse (DLBCL)

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lymphoma, Large B-Cell, Diffuse (DLBCL)

RecordFirmDate
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007) (NCT05406401)Merck Sharp & Dohme LLC2022-07-14
NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy (NCT02544724)Neumedicines Inc.2016-11-01

Track Lymphoma, Large B-Cell, Diffuse (DLBCL) automatically

Every clearance here is in the API, with alerts when new ones post.